Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 110, pseudogene (RN7SL110P) is a pseudogene of the 7SL RNA cytoplasmic family. Pseudogenes are nonfunctional segments of DNA that resemble known functional genes but have lost their capacity to encode RNA or protein due to disabling mutations[4][7]. RN7SL110P does not produce a functional product and is not associated with therapeutic or biological functions. It represents a relic of the gene encoding the functional 7SL RNA—which serves a crucial structural and regulatory role in the signal recognition particle (SRP) complex—but, as a pseudogene, RN7SL110P is generally considered biologically inactive and has no established disease role, drug interaction, or role as a biomarker[4][7]. There is no evidence supporting its use as a research or therapeutic target. Key points: - RN7SL110P is a pseudogene, meaning it is a non-functional sequence related to the gene for 7SL RNA[4][7]. - It is annotated but does not encode a functional RNA or protein and is not implicated in any known biological process or disease context[4][7]. - It is not considered a valid drug target and has no clinical relevance as a receptor, enzyme, or other functional biomolecule. If you require structured information for the true 7SL RNA or related SRP components with biological functions, consider the canonical "RNA, 7SL, cytoplasmic 1" (RN7SL1), not pseudogenes such as RN7SL110P[3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 110, pseudogene (RN7SL110P).